Incyte Corp. (INCY)$97.16
Market Cap: 12.02 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Incyte Corp. (INCY).
HEALTHCARE
BIOTECHNOLOGY
DCF ready
Valuation
6.3x
EV/FCF, 15.8% FCF yield
Quality
24.9%
ROIC, 27.5% FCF margin
Growth
14.0%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 3.3x current ratio
Superinvestors
2
Top: Harry Burn (2.4%)
Strengths to research
- Revenue compounded at 14.0% over five years.
- Return on equity is strong at 24.9%.
- Free cash flow margin is healthy at 27.5%.
- Debt/equity looks manageable at 0.0x.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for INCY.
Grade B
71
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| INCY Target | Incyte Corp. | $12.0B | 15.2x | 6.3x | 24.9% | 14.0% | 27.5% | N/A | -1.9x | N/A |
| BMRN | BioMarin Pharmaceutical Inc. | $11.9B | 30.1x | 14.6x | 5.7% | 11.6% | 22.5% | N/A | -2.7x | N/A |
| MRNA | Moderna, Inc. | $10.8B | -6.5x | -4.0x | -32.6% | 19.3% | -106.2% | N/A | N/A | N/A |
| ROIV | Roivant Sciences Ltd | $8.3B | -55.5x | -9.0x | -6.6% | -19.1% | -9183.5% | N/A | N/A | N/A |
| TECH | Bio-Techne Corp. | $7.9B | 104.8x | 30.1x | 3.8% | 10.5% | 21.0% | 64.8% | -0.8x | N/A |
| RPRX | Royalty Pharma plc | $19.0B | 30.6x | 11.0x | 4.1% | 2.3% | 104.7% | N/A | 5.3x | N/A |
| HALO | Halozyme Therapeutics | $7.5B | 26.7x | 14.7x | 14.5% | 39.2% | 46.2% | N/A | 4.2x | N/A |
| BBIO | BridgeBio Pharma Inc. | $7.3B | -18.3x | -19.5x | N/A | 127.4% | -89.0% | N/A | N/A | N/A |
| LEGN | Legend Biotech Corp. | $6.1B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for INCY (annual).
2 superinvestors own INCY
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 12,252,356 | $1.2B | 0.63% | 0.0% |
| Harry Burn Sound Shore | 767,829 | $72M | 2.42% | 0.0% |